Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor.
Overview
publication date
- November 15, 2001
published in
Research
keywords
- Antimetabolites, Antineoplastic
- Fluorouracil
- Oxidoreductases
- Oxidoreductases Acting on CH-CH Group Donors
Identity
Scopus Document Identifier
- 0035890826
Digital Object Identifier (DOI)
- 10.1200/JCO.2001.19.22.4267
PubMed ID
- 11709571
Additional Document Info
has global citation frequency
volume
- 19
issue
- 22